Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and U.S. markets.
"We get inquiries from nurses regularly asking when they can have the product" said Marcus Bech, CEO of Droplet IV. "This funding will enable us to make it available to our customers already next year, and I am I'm incredibly proud to have attracted investors with such deep expertise and commitment to help us fulfill this mission"
Automated IV flushing is gaining increased recognition in clinical settings - especially in areas where accurate medication dosing is critical. Yet no streamlined, automatic solutions currently exist. Nurses are often burdened with time-consuming manual flushing procedures that introduce variability and increase the risk of error.
"I'm excited to see Droplet IV speeding up access to this much-needed technology," said Lisa Gorski, a leading U.S.-based Key Opinion Leader (KOL) in IV therapy and Clinical Advisor to Droplet IV. "Nurses need simple, reliable tools to ensure safe and consistent flushing without it becoming a daily burden."
